Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
NEW YORK Johnson & Johnson, after a review, has consolidated U.S. creative duties on more than 35 prescription drug brands at WPP Group and Interpublic Group. Estimated total revenue on the business exceeds $100 million.
Sources said the split is nearly even both in terms of revenue and number of brands. It was not immediately clear, however, how many brands each holding company gained versus simply retained.
The review began with six holding companies and was reduced to four — IPG, WPP, Havas and inVentiv Health — before J&J chose two, said sources.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in